EGFR and neoplasm: The pivotal role of MIG6 segment 1/2 domains and phosphorylation at Y394/Y395 residues in the tumor suppressing activity of MIG6 was further explored through an in vitro kinase assay utilizing purified EGFR L858R mutant and MIG6 GST fusion proteins [19].